# Abbvie Biotechnology Ltd., Barceloneta, PR – FDA Inspections

Source: https://www.keypedia.com/companies/abbvie-biotechnology-ltd/b438b15a-033c-469a-8973-66b6506bba41

> Inspection records and compliance data for Abbvie Biotechnology Ltd. in Barceloneta, Puerto Rico. 11 FDA inspections on record, 5 Form 483s, last inspected June 10, 2026.

---

## Details

- Name: Abbvie Biotechnology Ltd.
- FEI Number: 3004620772
- Address Line 1: Road No 2 Km 59.2
- City: Barceloneta
- State: Puerto Rico
- Zip Code: 00617
- Country Name: United States
- Address: Road No 2 Km 59.2, Barceloneta, Puerto Rico 00617, United States
- Country: United States

## Related Documents

- [483 - Abbvie Biotechnology Ltd. - Unknown Date](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/b841e8d1-f95e-4ef1-bf9f-48c8f728cd44) — source: FDA, date: Invalid Date
- [483 - Abbvie Biotechnology Ltd. - 2026-06-10](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/82189424-eaad-4d9f-b8f2-3ec9a752cbd0) — source: FDA, date: June 10, 2026
- [FDA Inspection 1321476 - Abbvie Biotechnology Ltd. - 2026-06-10](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/5171fca6-80bf-44ca-b188-290a1bc76d8e) — source: FDA, date: June 10, 2026
- [483 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/fc6e7103-fba8-48a2-aaec-eae25e1f9e30) — source: FDA, date: October 30, 2023
- [FDA Inspection 1222107 - Abbvie Biotechnology Ltd. - 2023-10-30](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/fbc58704-0c5e-4f2c-8caa-a8e38cd2ba1a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 30, 2023
- [EIR - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/eir/abbvie-biotechnology-ltd/60b66384-af33-4ed5-93d8-e8d6f46a6c62) — source: FDA, date: March 25, 2019
- [483 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/483/abbvie-biotechnology-ltd/21216898-f0d2-4e1d-a352-c04132283cdb) — source: FDA, date: March 25, 2019
- [FDA Inspection 1084057 - Abbvie Biotechnology Ltd. - 2019-03-25](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/8a1c2a7f-d230-419e-8259-9a4045db92d1) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 25, 2019
- [FDA Inspection 1055102 - Abbvie Biotechnology Ltd. - 2018-06-01](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/6ebd3fac-5fb5-4657-a309-9546c0d43e1b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 1, 2018
- [FDA Inspection 1012249 - Abbvie Biotechnology Ltd. - 2017-04-28](https://www.keypedia.com/records/fda_inspections/abbvie-biotechnology-ltd/086cba85-e6e5-48ec-a35e-02b4f9600118) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 28, 2017
- [EIR - Abbvie Biotechnology Ltd. - 2017-01-13](https://www.keypedia.com/records/eir/abbvie-biotechnology-ltd/b46b0168-1899-4d02-b119-b2104039df67) — source: FDA, date: January 13, 2017
- FDA Inspection 1001477 - Abbvie Biotechnology Ltd. - 2017-01-13 — source: FDA, date: January 13, 2017
- FDA Inspection 969277 - Abbvie Biotechnology Ltd. - 2016-03-24 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 24, 2016
- FDA Inspection 887947 - Abbvie Biotechnology Ltd. - 2014-07-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2014
- FDA Inspection 791758 - Abbvie Biotechnology Ltd. - 2012-07-12 — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 12, 2012
- FDA Inspection 720207 - Abbvie Biotechnology Ltd. - 2011-04-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 29, 2011

## Related Companies

- [Wacker Biotech B.V.](https://www.keypedia.com/companies/wacker-biotech-bv/9bd47c05-6585-4710-a9ea-4bd04e15dd4f)
- [Sun Pharmaceutical Medicare Limited](https://www.keypedia.com/companies/sun-pharmaceutical-medicare-limited/bcde6f4d-9644-445c-b813-cb49ed881f97)
- [Boehringer Ingelheim Biopharmaceuticals (China) Ltd.](https://www.keypedia.com/companies/boehringer-ingelheim-biopharmaceuticals-china-ltd/be450a8b-4f71-4f06-96b3-908a2ed1b580)
- [BSP Pharmaceuticals SpA](https://www.keypedia.com/companies/bsp-pharmaceuticals-spa/cbf52ec3-50e2-4cf1-9f81-f0f7a74473fc)
- [Regeneron Pharmaceuticals Inc](https://www.keypedia.com/companies/regeneron-pharmaceuticals-inc/cd765cfa-95e6-4023-ade2-0ffa382fe2c7)
- [Chugai Pharma Manufacturing Co. Ltd.](https://www.keypedia.com/companies/chugai-pharma-manufacturing-co-ltd/09ba6515-9227-444c-a24c-a6cb8da9e235)
- [Avista Pharma Solutions, Inc. dba Cambrex](https://www.keypedia.com/companies/avista-pharma-solutions-inc-dba-cambrex/ca9e4205-cd7f-44bd-8dbe-a9d98be57047)
- [Alexion Pharma International Operations Unlimited Co.](https://www.keypedia.com/companies/alexion-pharma-international-operations-unlimited-co/7c523c79-b4b1-4a47-8393-141753fd60e8)
- [Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.](https://www.keypedia.com/companies/second-tokushima-factory-otsuka-pharmaceutical-co-ltd/d07820ec-a994-41cb-b667-509183a6cc4a)
- [Janssen Biotech, Inc.](https://www.keypedia.com/companies/janssen-biotech-inc/5374365d-a0df-4a87-ad3d-2714628d3e57)

## Related Officers

- [Ramesh Potla](https://www.keypedia.com/people/ramesh-potla/0df722fa-b514-49ac-8fcd-58363e086d32)
- [Principal Consultant- CMC Biologics, Former FDA regulator with expertise in CMC and GMP for Biologics](https://www.keypedia.com/people/steven-e-bowen/0e32c7e6-285b-4cf1-90e1-8a7a12a38b0c)
- [Investigator](https://www.keypedia.com/people/noreen-muniz/0bb20d12-62ad-42aa-8b0a-c44b339d413f)
- [Lilia M Lugo](https://www.keypedia.com/people/lilia-m-lugo/bd409997-f589-4d2d-b7ba-4b52f222e43e)
